Health Care/Hospital
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally
* Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials inChina. * BeiGene and Chime Biologics establish strategic cooperation to facilitate IND applications overseas and clinical trial materials supply. SHANGHAI, Ju...
2023-06-30 20:15
2666
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 29, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...
2023-06-29 21:26
2441
Jowell Global Ltd. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement
SHANGHAI, June 29, 2023 /PRNewswire/ -- Jowell Global Ltd. ("Jowell Global" or the "Company") (NASDAQ: JWEL), one of the leading cosmetics, health and nutritional supplements, and household products e-commerce platforms inChina, today announced that, onJune 27, 2023, the Company received a writte...
2023-06-29 20:00
3760
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial
* Significant improvement in Overall Response Rate (83%) compared with matched case control group (45%). * Significant overall survival advantage, with a 46% reduction in the risk of death. * Excellent safety profile and significant efficacy bolster HaemaLogiX's plan to progress further Kap...
2023-06-29 19:00
1805
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer
BEIJING, KYOTO and BOSTON, June 29, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced clinical results of its novel KRAS G12C inhibitor glecirasib monotherapy and in combination therapy with cetuximab to treat KRAS G...
2023-06-29 16:31
1885
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics
SYDNEY, June 28, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the establishment of a ...
2023-06-28 20:58
2328
Flat Medical Expands Leadership Team to Manage Growth in Europe and the United States
TAIPEI, June 28, 2023 /PRNewswire/ -- Flat Medical Co. Ltd., a leading MedTech company specializing in safety solutions for anesthesia and critical care, is pleased to announce the appointment of two executives who will spearhead the company's expansion inEurope and America. Jan Wormmeester has b...
2023-06-28 20:30
1826
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
SHANGHAI, June 28, 2023 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as Sanyou) and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963) (hereinafter referred to asHuadong Medicine), signed...
2023-06-28 20:00
1919
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite
* CBL-514 is the only non-invasive product that can improve 1-level of cellulite severity two weeks after a single treatment. * The highest dose of CBL-514 treatment demonstrated the best efficacy, 87.5% of thighs achieved at least 1-level improvement in cellulite severity two weeks after CBL...
2023-06-28 18:30
1866
Quhuo Creates a Warm and Supportive Work Environment for Deaf-Mute Riders
BEIJING, June 28, 2023 /PRNewswire/ -- "I joined Quhuo as a delivery rider in
2020 and have been working for three years now, and joining Quhuo has been a
great blessing for me." Zhang Xueqing expresses immense gratitude for becoming
a delivery rider forQuhuo Limited
2023-06-28 18:00
2159
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
HONG KONG, June 27, 2023 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltdtogether with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu Biopharm"), a non-wholly owned subsidiary of Company, has received a drug registration approval from the Natio...
2023-06-28 09:57
1917
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investigation showed patients treated with MINJUVI had prolonged, durable responses[2] SINGAPORE, June 27, 2023 /PRNewswire/ -- Independent biopharmaceutical ...
2023-06-28 04:00
1888
Momcozy Answers Challenges of Modern Motherhood with Thoughtfully Designed Products at Great Prices
NEW YORK, June 27, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and
baby brand endorsed by over two million moms globally, is excited to announcei
ts official website
2023-06-27 23:00
1837
AI Diagnostic Platform Company Noul Releases 2022-2023 Sustainability Report
* Publish the 3rd sustainability report and self-disclose to DART electronic disclosure system * Disclose key achievement of 5 sustainability focus areas for communicating with stakeholders * Systematize Noul Hybrid Business Model that creates both business and social values in an integrate...
2023-06-27 21:00
2082
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST
* INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) * The results of a comprehensive 483-sample case-control study established that INOVIQ's SubB2M/CA15-3 blood test significantly outperformed a ...
2023-06-27 19:00
2062
Innovative paper-like, battery-free, AI-enabled sensor for holistic wound monitoring
SINGAPORE, June 27, 2023 /PRNewswire/ -- Timely and effective monitoring of wound healing status is critical to wound care and management. Impaired wound healing, such as chronic wounds (i.e. those that do not heal after 3 months) and post-burn pathological scars, could result in life-threatening...
2023-06-27 16:53
2139
Momcozy Aims to Empower Breastfeeding Moms with Online Seminar After Successful FIME 2023 Exhibit
NEW YORK, June 26, 2023 /PRNewswire/ -- Momcozy
2023-06-27 10:00
1764
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research
CHENGDU, China, June 26, 2023 /PRNewswire/ -- HitGen Inc. ("HitGen", SSE: 688222.SH) has recently launched a newly upgraded version of its OpenDEL™ product, a self-service screening kit for novel molecules. It contains 65% more DEL libraries than the previous version, and with over 3 billion comp...
2023-06-26 21:30
2462
MEDICAL IP Received US FDA 510(k) Clearance for DeepCatch, AI Software for Whole-Body Composition CT Quantification
* The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nervous system in whole-body CT * Validation using multi-site and multi-racial CT data in the US… "We will create a new global standard for body com...
2023-06-26 19:00
1929
VitaDairy Vietnam Secures the No. 1 Partner of Global Colostrum Leader
VitaDairy Vietnam Joint Stock Company (VitaDairy), a prominent player among Vietnam's top three largest powdered milk manufacturers, has achieved a significant milestone by establishing itself as the No.1 partner of Pantheryx ( USA), the world's largest colostrum manufacturing group. The certifica...
2023-06-26 09:30
2419
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8005
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7400